title: Mixing Pens and the Future of Diabetes Drugs.
abstract: With the availability of a smaller mixing pen, mass marketing of less stable medications is possible. Bidureon is one such medication, and the properties of its pen are discussed along with the prospects for future mixing pens.
authors.affiliation: Diabetes Technology Consultants, Wyckoff, NJ, USA diabetes_consultants@yahoo.com.
authors.forename: Barry H
authors.initials: BH
authors.lastname: Ginsberg
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000188:drug therapy*; D000077270:Exenatide; D006801:Humans; D006943:Hyperglycemia / Q000188:drug therapy*; D007279:Injections, Subcutaneous / Q000295:instrumentation*; D010455:Peptides / Q000008:administration & dosage*; D013594:Syringes; D014688:Venoms / Q000008:administration & dosage*
chemical_list: D010455:Peptides; D014688:Venoms; D000077270:Exenatide
keywords: FDA; exenatide; mixing pen; pen